News Minimalist logo

GLP-1 drugs like Ozempic may reduce cancer risk

Quartz — July 5, 2024, 09:00 PM UTC

Summary: A study published in JAMA Network Open suggests that GLP-1 drugs like Ozempic may reduce the risk of obesity-related cancers in type 2 diabetes patients. Researchers analyzed 1.6 million patients and found a significant risk reduction in 10 out of 13 types of cancers. GLP-1 treatments mimic a blood sugar-regulating hormone. Novo Nordisk's Ozempic and Eli Lilly's Mounjaro are popular GLP-1 drugs with weight loss benefits. Further research on cancer prevention benefits is recommended.

Full article

Article metrics

The article metrics are deprecated.

I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.

Timeline:

  1. [3.2]
    Weight loss drugs may enhance brain health in diabetes (Gizmodo)
    57d 5h
    Source
  2. [4.5]
    GLP-1 drugs offer benefits beyond obesity and diabetes (News-Medical.Net)
    57d 11h
    Source
  3. [3.3]
    Dr. Daniel Drucker discusses future of Ozempic-like drugs (New York Post )
    62d 3h
    Source
  4. [4.0]
    Semaglutide not linked to higher neuropsychiatric risks in T2DM (News-Medical.Net)
    63d 11h
    Source
  5. [2.7]
    Oral semaglutide matches DPP-4i in T2D adherence, persistence (News-Medical.Net)
    64d 18h
    Source
  6. [4.6]
    Ozempic linked to cognitive benefits in diabetes patients (PMLiVE)
    65d 10h
    Source
  7. [3.2]
    AI analysis of Reddit shows interest in GLP-1 drugs for weight loss and mental health benefits (News-Medical.Net)
    65d 20h
    Source
  8. [2.5]
    Semaglutide may pose risk of vision loss: Study urges caution (Business Standard)
    66d 17h
    Source
  9. [4.7]
    Ozempic improves heart and kidney health for diabetes patients (Sydney Morning Herald)
    67d 13h
    Source
  10. [4.9]
    Semaglutide (Ozempic) may reduce dementia risk and nicotine cravings (Neuroscience News)
    68d 1h
    Source
  11. [3.2]
    Ozempic linked to lower dementia risk, nicotine use - study (The Straits Times)
    68d 4h
    Source
  12. [3.2]
    Ozempic linked to lower dementia risk, nicotine use in study (The Globe and Mail)
    68d 4h
    Source
  13. [3.9]
    Antidiabetic drugs linked to lower dementia risk in T2DM (News-Medical.Net)
    68d 5h
    Source
  14. [4.0]
    Ozempic linked to lower dementia rate in Oxford study (BNN Bloomberg)
    68d 13h
    Source
  15. [3.5]
    Ozempic and similar drugs may lower cancer risks (Forbes Australia)
    68d 18h
    Source
  16. [3.3]
    GLP-1 agonists lower dementia risk for diabetes patients (PsyPost)
    68d 21h
    Source
  17. [3.9]
    Weight-loss jabs lower cancer risk compared to insulin - study (The Conversation)
    69d 6h
    Source
  18. [4.7]
    GLP-1 agonists reduce cancer risk in type 2 diabetes (Inside Precision Medicine)
    70d 6h
    Source
  19. [3.4]
    GLP-1s reduce cancer risk in type 2 diabetes patients (PMLiVE)
    70d 10h
    Source
  20. [3.9]
    GLP-1 drugs linked to lower cancer risks in diabetes patients (Ars Technica)
    71d 6h
    Source
  21. [3.5]
    Semaglutide linked to rare eye disease causing vision loss (ScienceAlert)
    71d 11h
    Source
  22. [2.2]
    Semaglutide linked to higher risk of NAION in study (The Express Tribune)
    72d 9h
    Source
  23. [2.5]
    Semaglutide (Ozempic) linked to increased risk of blindness (Insight)
    72d 18h
    Source
  24. [5.5]
    GLP-1 agonists like Ozempic lower cancer risks in study (ScienceAlert)
    72d 19h

    ScoresSource
  25. [5.3]
    GLP-1 meds like Ozempic, Wegovy may lower cancer risk (CTV News)
    73d 8h

    ScoresSource
  26. [4.4]
    GLP-1 diabetes drugs reduce cancer risk, study finds (The Manila Times)
    74d 6h
    Source
  27. [5.0]
    GLP-1 medications may lower risk of certain cancers (CNN)
    74d 21h

    ScoresSource
  28. [2.2]
    GLP-1s lower risk of 10 obesity-related cancers in diabetes (Medpage Today)
    75d 1h
    Source
  29. [5.1]
    GLP-1 treatments reduce cancer risk in diabetes patients (GMA News Online)
    75d 3h

    ScoresSource
  30. [5.1]
    GLP-1 drugs reduce cancer risks for diabetes patients (Finimize)
    75d 6h

    ScoresSource
  31. [1.3]
    Weight loss drugs linked to rare eye condition risk (India TV News)
    75d 18h
    Source
  32. [2.9]
    Weight-loss drugs may increase risk of rare blindness (Firstpost)
    76d 10h
    Source
  33. [3.2]
    Novo Nordisk weight loss drugs linked to rare eye condition (CNBC)
    76d 12h
    Source
  34. [3.3]
    Ozempic linked to rare blindness cases in study (Business Insider)
    77d 4h
    Source
  35. [3.2]
    Wegovy, Ozempic linked to sight-threatening eye disorder in study (GMA News Online)
    77d 6h
    Source
  36. [3.4]
    Weight loss and diabetes drugs linked to rare blindness risk (CNN)
    77d 7h
    Source
  37. [3.2]
    Weight-loss jabs linked to potential blindness risk in study (The Guardian)
    77d 7h
    Source